Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
huatenzi granules
- Development stage
- Unknown
- Lead developer
- Suzhong Pharmaceutical Group
- Administration
- Oral
01
Overview
Huatenzi Granules (花藤子颗粒) is a Traditional Chinese Medicine (TCM) product developed and marketed by Suzhong Pharmaceutical Group. It is an oral granule formulation primarily indicated for the treatment of acute urticaria (hives) associated with the wind-heat pattern in TCM. Its therapeutic actions include dispelling wind, relieving itching, and detoxifying pathogenic factors. Although categorized under anti-tumor products on the manufacturer's website, its primary clinical application and approved labeling focus on dermatological conditions. The product is typically packaged as 4g granules per sachet.
- Brand names
- 花藤子颗粒Huatenzi Granules
- Other names
- Huatenzi Keli
Beyond the preview
Go deeper on huatenzi granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on huatenzi granules.